Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Newspaper Article
|
People with depression see no immediate change from common GP assessment, study showsM2 Presswire, 2024-03-28COPYRIGHT 2024 Normans Media Ltd.Digital Resources/Online E-Resources |
|
2 |
Material Type: Newspaper Article
|
Clinique Partners with Icahn School of Medicine at Mount Sinai to Establish the Mount Sinai-Clinique Healthy Skin Dermatology CenterM2 Presswire, 2024-02-05COPYRIGHT 2024 Normans Media Ltd.Digital Resources/Online E-Resources |
|
3 |
Material Type: Newspaper Article
|
European Commission authorises GSK's Omjjara (momelotinib) | GSKM2 Presswire, 2024-01-30COPYRIGHT 2024 Normans Media Ltd.Digital Resources/Online E-Resources |
|
4 |
Material Type: Newspaper Article
|
Over £800m to boost innovation, growth and improve patient safetyM2 Presswire, 2022-10-14COPYRIGHT 2022 Normans Media Ltd.Digital Resources/Online E-Resources |
|
5 |
Material Type: Newspaper Article
|
Tinnitus Pipeline Research Report 2022: Comprehensive Insights About 8+ Companies and 8+ Pipeline DrugsM2 Presswire, 2022-07-19COPYRIGHT 2022 Normans Media Ltd.Digital Resources/Online E-Resources |
|
6 |
Material Type: Newspaper Article
|
Parents and Caregivers Report a Reduction in Anxiety and Distress in Young Cancer Patients Using the My Special Aflac DuckM2 Presswire, 2024-04-09COPYRIGHT 2024 Normans Media Ltd.Digital Resources/Online E-Resources |
|
7 |
Material Type: Newspaper Article
|
Chronic Myeloid Leukemia Pipeline Review, 2024 Updates | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | Kiadis Pharma, BioLineRx, LtdM2 Presswire, 2024-04-04COPYRIGHT 2024 Normans Media Ltd.Digital Resources/Online E-Resources |
|
8 |
Material Type: Newspaper Article
|
Bronchiolitis Obliterans Syndrome Key Companies, Emerging Therapies, and Pipeline AssessmentM2 Presswire, 2021-05-12COPYRIGHT 2021 Normans Media Ltd.Digital Resources/Online E-Resources |
|
9 |
Material Type: Newspaper Article
|
Non-Hodgkin Lymphoma Pipeline Assessment 2024: FDA Approvals, Therapies, Clinical Trials and Key Companies involved by DelveInsight | AstraZeneca, Baxter, Bayer, Bristol Myers Squibb, Teva PharmaM2 Presswire, 2024-03-08COPYRIGHT 2024 Normans Media Ltd.Digital Resources/Online E-Resources |
|
10 |
Material Type: Newspaper Article
|
Advanced Ovarian Cancer Pipeline Analysis, 2024 Updates | Latest FDA, EMA, and PMDA Approvals | Pfizer, Daiichi Sankyo, Astellas Pharma, Jiangsu HengRui, Boehringer Ingelheim, Impact TherapeuticsM2 Presswire, 2024-03-01COPYRIGHT 2024 Normans Media Ltd.Digital Resources/Online E-Resources |
|
11 |
Material Type: Newspaper Article
|
Chronic Lymphocytic Leukemia Pipeline and Clinical Trials Assessment, 2024 Updates: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Janssen RD, NovalGen, Genmab, AscentageM2 Presswire, 2024-02-21COPYRIGHT 2024 Normans Media Ltd.Digital Resources/Online E-Resources |
|
12 |
Material Type: Newspaper Article
|
HER2-Positive Breast Cancer Pipeline Review | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, and Treatment Outlook | Roche Pharma AG, Dizal Pharma, Greenwich LifeSciences, AmbrxM2 Presswire, 2023-12-08COPYRIGHT 2023 Normans Media Ltd.Digital Resources/Online E-Resources |
|
13 |
Material Type: Newspaper Article
|
Bone Therapeutics treats first patients in ALLOB Phase IIb tibial fracture studyM2 Presswire, 2021-01-12COPYRIGHT 2021 Normans Media Ltd.Digital Resources/Online E-Resources |
|
14 |
Material Type: Newspaper Article
|
Trial results give hope to patients with severe eye conditionM2 Presswire, 2023-10-27COPYRIGHT 2023 Normans Media Ltd.Digital Resources/Online E-Resources |
|
15 |
Material Type: Newspaper Article
|
Metastatic Pancreatic Cancer Pipeline, Clinical Trials Assessment, NDA Approvals 2023 (Updated) | Salspera, BioLineRx, Ocuphire Pharma, Incyte Corporation, Eli Lilly and Company, RexahnM2 Presswire, 2023-07-17COPYRIGHT 2023 Normans Media Ltd.Digital Resources/Online E-Resources |
|
16 |
Material Type: Newspaper Article
|
Inflammatory Pain Pipeline and Clinical Trials Pipeline Analysis 2023 (Updated): 3+ Companies are working to improve the Treatment of Space | Norpharma, Parexel, Pfizer, GE Healthcare, and othersM2 Presswire, 2023-07-17COPYRIGHT 2023 Normans Media Ltd.Digital Resources/Online E-Resources |
|
17 |
Material Type: Newspaper Article
|
Grifols meets enrollment target in phase 3 study of two dose regimens of Prolastinreg;-C in patients with emphysema due to alpha-1-antitrypsin deficiencyM2 Presswire, 2023-07-14COPYRIGHT 2023 Normans Media Ltd.Digital Resources/Online E-Resources |
|
18 |
Material Type: Newspaper Article
|
Grifols meets enrollment target in phase 3 study of two dose regimens of Prolastin®-C in patients with emphysema due to alpha-1-antitrypsin deficiencyM2 Presswire, 2023-07-14COPYRIGHT 2023 Normans Media Ltd.Digital Resources/Online E-Resources |
|
19 |
Material Type: Newspaper Article
|
Ayurveda Introduces a Revolutionary Treatment for Kidney Failure Without DialysisM2 Presswire, 2023-03-20COPYRIGHT 2023 Normans Media Ltd.Digital Resources/Online E-Resources |
|
20 |
Material Type: Newspaper Article
|
Addiction Disorders Drugs Market Report 2022: Increasing Prevalence of Addictive Substances Such as Alcohol, Tobacco, and Drugs Among All Age Groups Drives GrowthM2 Presswire, 2023-01-16COPYRIGHT 2023 Normans Media Ltd.Digital Resources/Online E-Resources |